Combined with exercise and a low-calorie diet, the Wegovy pill is intended for use in people with overweight, obesity, or ...

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

Novo Nordisk executive Dave Moore touted high interest in Wegovy's oral version of its injectable GLP-1 weight-loss ...

Novo Nordisk’s Wegovy weight loss pill hit U.S. pharmacies this week. Here’s how it works, who qualifies, how to take it, ...

GLP-1 weight-loss pills appear to be just as effective as injections, with clinical trials showing similar average weight ...

There are two drugs on the market - semaglutide, marketed under the brand name Wegovy, and tirzepatide, sold as Mounjaro.

People who stop taking weight-loss jabs such as Wegovy regain pounds much faster than those who halt exercising and dieting, ...

Weight-loss injections have transformed obesity treatment in recent years, but new research suggests the benefits may fade ...

Eli Lilly won approval for its tirzepatide under the names Mounjaro for type 2 diabetes and Zepbound for weight loss -- in ...

The pill version of popular weight-loss drug Wegovy became available in the U.S. on Monday, offering patients a daily oral ...

Eli Lilly's research and development head said on Monday the company will have plenty of supply to launch its ...

Glucagon-like peptide-1 receptor agonists (GLP-1s or GLP-1RAs) – also known as weight-loss jabs – are medicines that help ...